2016 Mar 21
Last Requests
Holly Prigerson and husband Paul Maciejewski promote compassionate care for cancer patients at the end of their lives. Read more
2016 Mar 21
Enzyme inhibitor looks promising against many forms of cancer
Paraskevi Giannakakou, Ph.D., has collaborated with colleagues in Ithaca to develop an inhibitor of oncoprotein c-Myc. Read more
2016 Mar 18
Novel agents on horizon for follicular lymphoma
A diverse collection of novel agents are on the horizon that could further improve the long-term outcomes experienced by patients with follicular lymphoma, according to John Leonard, M.D. Read more
2016 Mar 16
Some pediatric regimens can be successful in adults with ALL
Gail Roboz, M.D., discusses the differences in pediatric and adult cute lymphoblastic leukemia. Read more
2016 Mar 15
Fulvestrant plus palbociclib effective in metastatic breast cancer
Selina Chen-Kiang, Ph.D., comments on a new treatment option for women with advanced breast cancer. Read more
2016 Mar 15
Vyxeos trial shows survival boost in AML
Drug shows promise for extending survival for patients with acute myeloid leukemia, according to Gail Roboz, M.D. Read more
2016 Mar 15
Future treatment approaches in Mantle Cell Lymphoma
Peter Martin, M.D., discusses future treatment approaches in the field of mantle cell lymphoma. Read more
2016 Mar 14
Selecting patients with HCC appropriate for minimally invasive therapy
David C. Madoff, M.D., discusses selecting patients with hepatocellular carcinoma (HCC) who are candidates for minimally invasive therapy. Read more
2016 Mar 11
Partnering up to test radiation immunotherapy treatments
Silvia Formenti, M.D., is working with Janssen Biotech to explore new cancer treatments combining radiation and immunotherapy. Read more
2016 Mar 11
What you should know about colon cancer screening
Manish Shah, M.D., discusses advances in colorectal cancer treatment. Read more
2016 Mar 10
New drugs make treatment of CLL like a chronic disease
Patients diagnosed with chronic lymphocytic leukemia who are treated with new targeted agents may have a normal life span, according to John Allan, M.D. Read more
2016 Mar 09
New approach to treating aggressive B-cell lymphomas
Leandro Cerchietti, M.D., has identified a potential new strategy for the treatment of aggressive diffuse large B-cell lymphomas (DLBCL) called double and triple hit lymphomas. Read more
2016 Mar 08
Cancer research fund set up at Weill Cornell in honor of Garrett
A memorial fund for Cornell President Elizabeth Garrett has been set up to fund colon cancer research at the Meyer Cancer Center. Read more
2016 Mar 07
Cancer and virtual reality
Olivier Elemento, Ph.D., discusses the use of virtual reality in cancer research. Read more
2016 Mar 07
Team finds new approach to curbing cancer cell growth
New drug targeting the serine pathway could be used to treat certain types of breast cancer, lung cancer and melanoma. Read more
2016 Mar 07
Clearing a hurdle: Lab IDs potential target in kidney cancer
The lab of Lorraine Gudas, Ph.D., has identified a gene that may provide a new, super specific target for drugs that could stop kidney cancer progression in its tracks. Read more
2016 Mar 03
Palbociclib sensitizes myeloma cells to immunomodulatory drugs
Selina Chen-Kiang, Ph.D., discusses the effect of immunomodulatory drugs on myeloma cells Read more
2016 Feb 29
New York City: En Route to a Bio Cluster
Editorial about New York City's life sciences scene mentions Lewis Cantley, Laurie Glimcher, and the Meyer Cancer Center. Read more
2016 Feb 24
The cancer campaign that got personal
Patient Anne Glauber discusses life with pancreatic cancer, and her doctor, Allyson Ocean. Read more
